BlackWall
Blooms the Chemist
Haoma Mining
Moneytech
Pelathon
Planet Group Holdings
PrimaryMarkets
VGW Holdings
XYZ Ltd
Imugene
Capital Raises
Secondary Trading
.png)
Biopharmaceutical Company founded by Australian Nobel Laureate - Patented Product for Treatments of Allergy Indications
| Categories: | Securities, Unissued Securities |
| Sale Type: | Price on Application |
| Price Guide: | AUD A$3.5M raise at A$0.05 per share - A$2.75M already raised (pre-money valuation of A$1.57M) |
| Status: | Closed |
Summary:
Unlisted Australian company founded by Australian Nobel Laureate to develop and commercialise novel treatments in rapidly growing international market for allergic indications including childhood eczema, food allergies, allergic asthma. Funds required to complete pre-clinical studies and quality manufacture of patented product for use in animal safety studies and clinical trials.
Share this Listing
